Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Sarah A. MacLeish"'
Publikováno v:
Diabetes Spectr
Background Continuous glucose monitoring (CGM) can improve glycemic outcomes in pediatric type 1 diabetes management. However, its impact on the psychosocial functioning of caregivers is less well described. The objectives of this pilot study were to
Autor:
Amy Criego, Sarah A. Macleish, Jennifer L. Sherr, Jordan E. Pinsker, Ruth S. Weinstock, Anders L. Carlson, Anuj Bhargava, Richard M. Bergenstal, Thomas C. Jones, Daniel J. DeSalvo, Grazia Aleppo, Carol J. Levy, Bruce W. Bode, Sanjeev N. Mehta, Gregory P. Forlenza, Viral N. Shah, Bruce A. Buckingham, Irl B. Hirsch, David W Hansen, Sue A. Brown, Lori M. Laffel, Trang T. Ly
Publikováno v:
Diabetes Care
OBJECTIVE Advances in diabetes technology have transformed the treatment paradigm for type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study of the first tubeless, on-body automated insulin delivery system with
Autor:
Trang T. Ly, David W. Hansen, Sarah A. MacLeish, Daniel J. DeSalvo, Amy B. Criego, Bruce A. Buckingham, Melissa J. Schoelwer, Lori M. Laffel, Gregory P. Forlenza, Bruce W. Bode, Jennifer L. Sherr
Objective: Very young children with type 1 diabetes often struggle to achieve glycemic targets, putting them at risk of long-term complications and creating an immense management burden for caregivers. We conducted the first evaluation of the Omnipod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a059148f4bdfadbe531ac4ce3d2f75a9
https://doi.org/10.2337/figshare.19763350.v1
https://doi.org/10.2337/figshare.19763350.v1
Autor:
William H. Polonsky, Korey K. Hood, Carol J. Levy, Sarah A. MacLeish, Irl B. Hirsch, Sue A. Brown, Bruce W. Bode, Anders L. Carlson, Viral N. Shah, Ruth S. Weinstock, Anuj Bhargava, Thomas C. Jones, Grazia Aleppo, Sanjeev N. Mehta, Lori M. Laffel, Gregory P. Forlenza, Jennifer L. Sherr, Lauren M. Huyett, Todd E. Vienneau, Trang T. Ly
Publikováno v:
Diabetes research and clinical practice. 190
To evaluate psychosocial outcomes for adults with type 1 diabetes (T1D) using the tubeless Omnipod® 5 Automated Insulin Delivery (AID) System.A single-arm, multicenter (across the United States), prospective safety and efficacy study of the tubeless
Autor:
Joyce Keady, Marsha D. Marcus, Melinda Tung, Paula M. Trief, Ryan M. Farrell, Ruth S. Weinstock, Maria S. Rayas, Diane Uschner, Sarah A. Macleish, Lily Chao
Publikováno v:
Diabetes. 70
Aims: Diabetes distress (DD) is associated with poor health outcomes. Little is known about level of DD in young adults (YAs) with youth-onset type 2 diabetes (T2D) or individual factors associated with DD. Aims were to assess level of DD, and factor
Publikováno v:
Diabetes. 70
Objective: Insulin degludec (IDeg) is an ultra-long acting insulin that gives more flexibility with dose timing. Studies comparing the efficacy of IDeg to insulin glargine (IGlar) have conflicting results. Our aim was to compare glycemic control (HbA
Autor:
Carol J. Levy, Sarah A. Macleish, William H. Polonsky, Todd Vienneau, Lauren M. Huyett, Trang T. Ly, Korey K. Hood
Publikováno v:
Diabetes. 70
Autor:
Korey K. Hood, Sarah A. Macleish, Todd Vienneau, William H. Polonsky, Lauren M. Huyett, Carol J. Levy, Trang T. Ly
Publikováno v:
Diabetes. 70
Type 1 diabetes (T1D) is a lifelong disease that requires constant monitoring. New technologies seeking to relieve this burden must be user-friendly and provide treatment satisfaction to enable widespread adoption, glycemic benefit, and long-term suc
Autor:
Bruce A. Buckingham, Amy B. Criego, Bruce W. Bode, Daniel Desalvo, Trang T. Ly, Lori M. Laffel, Sue A. Brown, Gregory P. Forlenza, Jennifer Sherr, Sarah A. Macleish, David W. Hansen
Publikováno v:
Diabetes. 70
The Omnipod 5 System is a novel hybrid closed-loop (HCL) system with full on-body operation. A tubeless insulin pump containing a personalized MPC algorithm communicates directly with a Dexcom G6 CGM to automate insulin delivery. Following demonstrat
Autor:
Amy Criego, Sanjeev N. Mehta, Richard M. Bergenstal, Lori M.B. Laffel, David W Hansen, Daniel J. DeSalvo, Anuj Bhargava, Bruce A. Buckingham, Sue A. Brown, Bruce W. Bode, Jennifer Sherr, Trang T. Ly, Grazia Aleppo, Sarah A. Macleish, Thomas C. Jones, Ruth S. Weinstock, Gregory P. Forlenza, Irl B. Hirsch, Viral N. Shah, Carol J. Levy, Anders L. Carlson
Publikováno v:
Diabetes. 70
Safe and effective use of the Omnipod 5 System was demonstrated in adults and children with type 1 diabetes (T1D) during a 3-month pivotal study. Longer studies are needed to evaluate durability of glycemic benefit. Those completing the pivotal study